Bio-Rad Laboratories Inc - Class A

NYSE: BIO
$278.21
-$7.07 (-2.5%)
Closing price April 24, 2024
Bio-Rad Laboratories Inc, headquartered in Hercules, California, is a global leader in developing and providing innovative tools for the life science research and clinical diagnostic markets. Founded in 1952, the company specializes in products and systems for separating, purifying, characterizing, and quantitating biological materials such as cells, proteins, and nucleic acids. Bio-Rad serves a wide range of customers, including those in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Additionally, it supplies test systems, informatics systems, and quality controls for healthcare facilities. Bio-Rad markets its products worldwide, leveraging both a direct sales force and a network of distributors.
Friday's top analyst upgrades and downgrades included Advanced Micro Devices, Asana, Etsy, Exact Sciences, Guardant Health, Hilton Worldwide, Meta Platforms, MongoDB, Salesforce, ServiceNow, Sysco...
These four Jefferies stock picks in the health care space offer outstanding upside potential for investors long term and look like very solid ideas for the rest of 2021, especially with an overbought...